Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

17 Jan 2014 07:00

RNS Number : 8726X
BrainJuicer Group PLC
17 January 2014
Β 

Β 

Β 

Β 

Press Release 17 January 2014

Β 

Β 

BrainJuicer Group PLC

Β ("BrainJuicer" and the "Company")

Β 

Trading update

Β 

Innovative, international online market researcher BrainJuicer Group PLC (AIM: BJU) today releases the following update on trading during its financial year ended 31 December 2013. The Company will announce its final results on 21 March 2014.

Β 

Revenue for the year increased by 17% to over Β£24m, reflecting continued encouraging trading over the second half of the year. Our core UK and US businesses both performed well, and all of our operations, with the exception of Germany, delivered increased revenue. The results were bolstered by an excellent fourth quarter, historically a strong but unpredictable quarter, during which revenues were well ahead of those in the disappointing comparable 2012 period.

Β 

Administrative costs were well controlled through the year, increasing by around 7%. The return of strong revenue growth and lower cost growth resulted in profits bouncing back strongly after the decline last year. Pre-tax profit for the year will be approximately Β£3.5m compared to Β£1.5m in 2012 and Β£2.8m in 2011, substantially beating the current market expectation.

Β 

Cash generation during 2013 was particularly strong. Even after returning Β£1.5m to shareholders in October via a 12p per share special dividend, the Company ended the year with a cash balance of Β£6.2m, compared with Β£3.8m at the end of 2012. BrainJuicer has no debt.

Β 

During 2013 the Company made further operational and strategic progress - enhancing its reputation and credibility. As testimony to this, in a recent global survey of over 2,000 market research practitioners (the Greenbook Industry Trends survey), the Company was voted the most innovative market research firm for the third year in a row. BrainJuicer's approaches, centred on Behavioural Science, continue to gain endorsement within major international clients, and this bodes well for further long term growth.

Β 

The Company can be found at www.brainjuicer.com.

Β 

Β 

- Ends -

Β 

Β 

For further information, please contact:

Β 

BrainJuicer Group PLC

John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer www.brainjuicer.com

Β 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTUNAVRSUAAAAR
Date   Source Headline
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
12th Jul 20227:00 amRNSQuarterly Trading Update
30th Jun 20224:15 pmRNSHolding(s) in Company
30th Jun 20229:30 amRNSHolding(s) in Company
27th Jun 20223:00 pmRNSDirectorate Change
22nd Jun 20227:00 amRNSDistribution policy
6th Jun 20227:00 amRNSHolding(s) in Company
26th May 20221:15 pmRNSDirectorate Change
13th May 202212:15 pmRNSChange of Registered Office
27th Apr 20227:00 amRNSTrading Update
1st Apr 20222:00 pmRNSCompletion of Share Buyback Programme
25th Mar 20225:21 pmRNSTransaction in Own Shares
23rd Mar 20223:30 pmRNSTransaction in Own Shares
22nd Mar 20225:32 pmRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSUpdate re Stefan Barden
11th Mar 20226:00 pmRNSTransaction in Own Shares
11th Mar 20223:30 pmRNSHolding(s) in Company
4th Mar 20226:25 pmRNSTransaction in Own Shares
4th Mar 202210:15 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20224:15 pmRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTrading Update
21st Feb 20223:15 pmRNSTransaction in Own Shares
18th Feb 20225:31 pmRNSTransaction in Own Shares
16th Feb 20225:30 pmRNSTransaction in Own Shares
15th Feb 202210:15 amRNSTransaction in Own Shares
14th Feb 20225:02 pmRNSTransaction in Own Shares
11th Feb 20225:15 pmRNSTransaction in Own Shares
9th Feb 20223:45 pmRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTrading Update
4th Feb 202211:45 amRNSHolding(s) in Company
24th Jan 20225:50 pmRNSTransaction in Own Shares
21st Jan 20225:15 pmRNSTransaction in Own Shares
20th Jan 20225:15 pmRNSTransaction in Own Shares
12th Jan 202212:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.